Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window
Closure of Trading window29-06-2024
Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window
Closure of Trading windowNath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance under Reg 39 (3) for Details of Loss of Share Certificate.Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for FY 2024.Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance under Regulation 39(3) of SEBI, LODR Regulations, 2015. for details of loss of share certificate by the shareholder of the Company.Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings Call transcript held on 09th May 2024Nath Bio-Genes (India) Ltd - 537291 - Audio Recording Of Conference Call
Audio Recording of Conference call held on 09th May 2024 at 04:00 PM on Audited Financial Results of the Company.Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Share Certificate by the Shareholder.Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Audited Financial Results as on 31st March 2024.Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Outcome for Outcome Of Board Meeting Held On 08Th May 2024
Outcome of Board meeting held on 08th May 2024 for approval of 1. Audited Financial Results as on 31st March 2024. 2. Recommendation of Dividend by Board of Directors 3. Date of Annual General Meeting of the Company for financial year 2023-24Nath Bio-Genes (India) Ltd - 537291 - Audited Financial Results As At 31St March 2024
Outcome of Board Meeting of the Company held on 08th May 2024.